Clinical Trials in Colorado

Showing 5721-5740 of 18,143 trials

Vivacit-E Post-market Follow-up Study

NCT03226808

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

OsteoarthritisAvascular Necrosis of Bone of HipPost-traumatic; Arthrosis+1 more

Zimmer Biomet258 participantsStarted Oct 2013

Parker, Colorado, United States • Chapel Hill, North Carolina, United States • Charlotte, North Carolina, United States +2 more locations

COMPLETEDPhase 144 miles

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

NCT03664804

The study is designed as a multi-site, prospective, 15-month longitudinal, cohort study measuring CSF mHTT in participants with early manifest Stage I or Stage II Huntington's Disease (HD).

Huntington's Disease

Hoffmann-La Roche95 participantsStarted Dec 2018

Englewood, Colorado, United States • Washington D.C., District of Columbia, United States • Wichita, Kansas, United States +12 more locations

Vivacit-E Post-market Follow-up Study

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Find Trials by Condition in Colorado

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Philips Intracardiac Echocardiography (ICE) Clinical Registry

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Predictive Factors for Medullary Thyroid Cancer Aggressiveness